Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1201 AL 1215

Variable High-Frequency Deep Brain Stimulation of the Subthalamic Nucleus for Speech Disorders in Parkinson's Disease: A Case Report

Zhang C, Pan Y, Zhou H, Xie Q, Sun B, Niu CM, Li D.

Front Neurol. 2019 Apr 16;10:379. doi: 10.3389/fneur.2019.00379. eCollection 2019.

Variably protease-sensitive prionopathy: A differential diagnostic consideration for dementia

Kim SH, Yu MM, Strutt AM.

Neurol Clin Pract. 2019 Apr;9(2):145-151. doi: 10.1212/CPJ.0000000000000612.

Correction: The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis

Zhong R, Chen Q, Zhang X, Zhang X, Lin W.

PLoS One. 2019 May 1;14(5):e0216524. doi: 10.1371/journal.pone.0216524. eCollection 2019.

MDS evidence-based review of treatments for essential tremor

Ferreira JJ, Mestre TA, Lyons KE, Benito-León J, Tan EK, Abbruzzese G, Hallett M, Haubenberger D, Elble R, Deuschl G; MDS Task Force on Tremor and the MDS Evidence Based Medicine Committee.

Mov Disord. 2019 Jul;34(7):950-958. doi: 10.1002/mds.27700. Epub 2019 May 2.

Clinical and methodological challenges for assessing freezing of gait: Future perspectives

Mancini M, Bloem BR, Horak FB, Lewis SJG, Nieuwboer A, Nonnekes J.

Mov Disord. 2019 Jun;34(6):783-790. doi: 10.1002/mds.27709. Epub 2019 May 2.

Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?

Mariani LL, Doulazmi M, Chaigneau V, Brefel-Courbon C, Carrière N, Danaila T, Defebvre L, Defer G, Dellapina E, Doé de Maindreville A, Geny C, Maltête D, Meissner WG, Rascol O, Thobois S, Torny F, Tranchant C, Vidailhet M, Corvol JC, Degos B; NS-Park/F-CRIN Network study group.

Parkinsonism Relat Disord. 2019 Jul;64:226-234. doi: 10.1016/j.parkreldis.2019.04.012. Epub 2019 Apr 25.

[Pisa Syndrome - case report]

Sigmundsson FG, Stromqvist F, Karlsson B.

Laeknabladid. 2019 Mai;105(5):231-235. doi: 10.17992/lbl.2019.05.232.

Metabolic pattern analysis of (18)F-FDG PET as a marker for Parkinson's disease: a systematic review and meta-analysis

Gu SC, Ye Q, Yuan CX.

Rev Neurosci. 2019 May 3;30(7):743-756. doi: 10.1515/revneuro-2018-0061. Print 2019 Oct 25.

Disease-Associated Genetic Variation in Human Mitochondrial Protein Import

Nicolas E, Tricarico R, Savage M, Golemis EA, Hall MJ.

Am J Hum Genet. 2019 May 2;104(5):784-801. doi: 10.1016/j.ajhg.2019.03.019.

Parkinson's and Lewy body dementia CSF biomarkers

Parnetti L, Paciotti S, Farotti L, Bellomo G, Sepe FN, Eusebi P.

Clin Chim Acta. 2019 Aug;495:318-325. doi: 10.1016/j.cca.2019.04.078. Epub 2019 Apr 30.

Dopaminergic Vulnerability in Parkinson Disease: The Cost of Humans' Habitual Performance

Hernandez LF, Obeso I, Costa RM, Redgrave P, Obeso JA.

Trends Neurosci. 2019 Jun;42(6):375-383. doi: 10.1016/j.tins.2019.03.007. Epub 2019 Apr 30.

Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration

Tóth A, Antal Z, Bereczki D, Sperlágh B.

Neurochem Res. 2019 Oct;44(10):2413-2422. doi: 10.1007/s11064-019-02798-1. Epub 2019 May 4.

Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease

Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY.

J Bioenerg Biomembr. 2019 Jun;51(3):175-188. doi: 10.1007/s10863-019-09798-4. Epub 2019 May 3.

Assessing drug response in engineered brain microenvironments

Tate KM, Munson JM.

Brain Res Bull. 2019 Aug;150:21-34. doi: 10.1016/j.brainresbull.2019.04.027. Epub 2019 May 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias